Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis S Matza

Showing results (21-30 of 114) with videos related to

Pageof 12
Sort By:
Journal of Child Neurology|July 5, 2007
Cost-effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsyGregory de Lissovoy, Louis S Matza, Hannah Green, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Impact of atomoxetine on health-related quality of life and functional status in patients with ADHDLouis S Matza, Maria N Stoeckl, Jodi M Shorr, et al.
Advances in Therapy|February 12, 2026
Psychometric Validation of the Simplicity of Diabetes Treatment Questionnaire (Sim-Q) for Type 2 DiabetesKristina S Boye, Katelyn N Cutts, Karin S Coyne, et al.
Journal of Attention Disorders|September 15, 2010
Test-retest reliability of two patient-report measures for use in adults with ADHDLouis S Matza, David L Van Brunt, Charlotte Cates, et al.
Neurourology and Urodynamics|October 4, 2006
The responsiveness of the OAB-q among OAB patient subgroupsKarin S Coyne, Louis S Matza, Christine Thompson, et al.
Patient Related Outcome Measures|December 15, 2025
Validation of a Questionnaire for Assessing the Emotional Impact of Treatment for Type 2 DiabetesLouis S Matza, Katelyn N Cutts, Karin S Coyne, et al.
Journal of Medical Economics|June 2, 2020
Estimating health state utilities associated with a rare disease: familial chylomicronemia syndrome (FCS)Louis S Matza, Glenn A Phillips, Timothy A Howell, et al.
Journal of Patient-Reported Outcomes|June 1, 2026
Development of the Pediatric Type 2 Diabetes Impact Measure (P-TIM)Kristina S Boye, Katie D Stewart, Louis S Matza, et al.
Multiple Sclerosis and Related Disorders|August 23, 2019
Development of a brief clinician-reported outcome measure of multiple sclerosis signs and symptoms: The Clinician Rating of Multiple Sclerosis (CRoMS)Louis S Matza, Katie D Stewart, Glenn Phillips, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 19, 2005
Psychometric validation of the child health questionnaire (CHQ) in a sample of children and adolescents with attention-deficit/hyperactivity disorderAnne M Rentz, Louis S Matza, Kristina Secnik, et al.
Pageof 12

Showing results (21-30 of 114) with videos related to

Sort By:
Pageof 12
Journal of Child Neurology|July 5, 2007
Cost-effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsyGregory de Lissovoy, Louis S Matza, Hannah Green, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Impact of atomoxetine on health-related quality of life and functional status in patients with ADHDLouis S Matza, Maria N Stoeckl, Jodi M Shorr, et al.
Advances in Therapy|February 12, 2026
Psychometric Validation of the Simplicity of Diabetes Treatment Questionnaire (Sim-Q) for Type 2 DiabetesKristina S Boye, Katelyn N Cutts, Karin S Coyne, et al.
Journal of Attention Disorders|September 15, 2010
Test-retest reliability of two patient-report measures for use in adults with ADHDLouis S Matza, David L Van Brunt, Charlotte Cates, et al.
Neurourology and Urodynamics|October 4, 2006
The responsiveness of the OAB-q among OAB patient subgroupsKarin S Coyne, Louis S Matza, Christine Thompson, et al.
Patient Related Outcome Measures|December 15, 2025
Validation of a Questionnaire for Assessing the Emotional Impact of Treatment for Type 2 DiabetesLouis S Matza, Katelyn N Cutts, Karin S Coyne, et al.
Journal of Medical Economics|June 2, 2020
Estimating health state utilities associated with a rare disease: familial chylomicronemia syndrome (FCS)Louis S Matza, Glenn A Phillips, Timothy A Howell, et al.
Journal of Patient-Reported Outcomes|June 1, 2026
Development of the Pediatric Type 2 Diabetes Impact Measure (P-TIM)Kristina S Boye, Katie D Stewart, Louis S Matza, et al.
Multiple Sclerosis and Related Disorders|August 23, 2019
Development of a brief clinician-reported outcome measure of multiple sclerosis signs and symptoms: The Clinician Rating of Multiple Sclerosis (CRoMS)Louis S Matza, Katie D Stewart, Glenn Phillips, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 19, 2005
Psychometric validation of the child health questionnaire (CHQ) in a sample of children and adolescents with attention-deficit/hyperactivity disorderAnne M Rentz, Louis S Matza, Kristina Secnik, et al.
Pageof 12